Fuld

NOVEMBER 13, 2023

As families and friends gather to share gifts, feast on sweets, and light fireworks, we join in celebrating the rich tapestry of stories and customs that bring us all closer together The post Newsletter – November 2023 appeared first on Fuld & Co.

Documentation 52

Documentation 52

Fuld

JULY 27, 2023

The latest edition of our Fuld insights newsletter brings you a curated collection of industry insights, cutting-edge trends, and strategic advice to help you navigate today’s complex business landscape and gain a competitive edge. Join us in welcoming Amie to the team!

52

52

Fuld

SEPTEMBER 7, 2023

Read the case study… The post Newsletter – September 2023 appeared first on Fuld & Co. Read more… Sustainable innovation in the polymer industry Fuld partnered with a leading industrial polymer manufacturer to deliver sustainable innovation, reduce waste, and shave 1.5 years off their R&D timeline.

52

52

Fuld

OCTOBER 12, 2022

Welcome to the October edition of our newsletter. Here are our monthly highlights: Our monthly newsletter series brings you the latest insights and perspectives from Fuld experts. The post August Newsletter 2022 appeared first on Fuld & Co. Get in touch now!

52

52

Fuld

MARCH 9, 2023

Regards, Michele Sachar Chief Operating Officer | Fuld & Company The post Newsletter – March 2023 appeared first on Fuld & Co. In case you missed our recent webinar on How to Mitigate Cultural Bias in Market Research , don’t worry, we’ve got you covered! The replay is available here.

52

52

Fuld

JUNE 9, 2023

Contact Shiv The post Newsletter – June 2023 appeared first on Fuld & Co. Shiv Nayyar , Fuld’s Director of Consulting Services, will be there for the full four days and would love to connect with any clients or members of the Fuld community who will be on site, so if this is you, be sure to reach out.

Vaccines 52

Vaccines 52

Fuld

FEBRUARY 15, 2023

Read more… The post February Newsletter 2023 appeared first on Fuld & Co. Read how Fuld helped this company redesign its sales strategy–including lead sizing and territory design—to help it boost lead conversion by 8 percentage points and sales growth by 12 percentage points.

52

52

STAT

APRIL 15, 2024

  Sign up  to get our biotech newsletter in your inbox. Hi there, Meghana here — a little wistful about the departure of the illustrious Damian Garde but extremely excited about a fantastic newsletter co-author we’ll introduce soon. Want to stay on top of the science and politics driving biotech today? 

86

86

STAT

APRIL 12, 2024

  Sign up  to get our biotech newsletter in your inbox. I’ve had a wonderful time covering biotech here these last eight years, and that’s in no small part a testament to the clever and engaged readers of this very newsletter. Hello, everyone.

Vaccines 103

Vaccines 103

STAT

MARCH 7, 2024

I’m launching a weekly email newsletter starting on March 28. What should you expect to see in my newsletter each week? I’m really excited to get started and I hope you’ll find the newsletter worthy of your inbox real estate. Have you heard the news? One catch: We need you to sign up, which you can do here.

120

120

STAT

MARCH 21, 2024

I am one week away from the launch of my weekly email newsletter! What should you expect to see in my newsletter each week? Do you have a biotech-related question you want me to answer in the newsletter? It’s called Adam’s Biotech Scorecard, and it’s exclusively for STAT subscribers.

106

106

STAT

APRIL 5, 2024

  Sign up  to get our biotech newsletter in your inbox. There’s, of course, our podcast , “The Readout Loud,” and Adam Feuerstein’s spicy new newsletter , “Adam’s Biotech Scorecard. Meghana here.

107

107

STAT

APRIL 22, 2024

  STAT’s weekly newsletter following the flow of money in medicine.  You’re reading the web version of Health Care Inc.,    Sign up to get it in your inbox every Monday. 

Hospitals 116

Hospitals Insurance 116

STAT

APRIL 4, 2024

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. Luckily, this newsletter has arrived like a warm hug. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox. I want to hear from you!

105

105

STAT

APRIL 16, 2024

  Sign up  to get our biotech newsletter in your inbox. Want to stay on top of the science and politics driving biotech today?  Today, we dig into Biohaven’s plans and see Humira biosimilar prescriptions shoot up. Read the rest…

104

104

STAT

MARCH 4, 2024

  Sign up  to get our biotech newsletter in your inbox. In today’s newsletter, we discuss embryonic stem cell ethics, learn of parents searching for a treatment for their son’s ultra-rare neurological disease, and more. Want to stay on top of the science and politics driving biotech today? 

103

103

STAT

MARCH 14, 2024

I’m launching a weekly email newsletter starting on March 28. What should you expect to see in my newsletter each week? Have you heard the news? It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here.

127

127

STAT

APRIL 9, 2024

  Sign up  to get our biotech newsletter in your inbox. Want to stay on top of the science and politics driving biotech today?  Hello, everyone. Damian here with an update on the biotech market, a look at the future of genome editing, and the evolving definition of “insider trading.”

Vaccines 115

Vaccines 115

STAT

APRIL 23, 2024

  Sign up  to get our biotech newsletter in your inbox. I’m Elaine, the new co-author of this newsletter. Want to stay on top of the science and politics driving biotech today?  Don’t recognize the avatar above? I’m very excited to be here. Scroll

FDA 92

FDA 92

STAT

APRIL 11, 2024

  Sign up  to get our biotech newsletter in your inbox. Want to stay on top of the science and politics driving biotech today?  Hello, everyone. Damian here with a look at a biotech deal with a lengthy backstory, the tyranny of gas prices, and the latest shakeup at BIO. Read the rest…

Vaccines 96

Vaccines 96

STAT

MARCH 27, 2024

New biotech newsletter launching tomorrow. Don’t miss out. Good morning, everyone. Damian here with the details on a potentially major drug approval, an idea to make CAR-T more equitable, and the slow launch of a gene therapy. Read the rest…

FDA 105

FDA 105

STAT

APRIL 8, 2024

  Sign up  to get our biotech newsletter in your inbox. Want to stay on top of the science and politics driving biotech today?  Hi, it’s Meghana. Lots happened this past weekend!

106

106

STAT

APRIL 25, 2024

Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  You’re reading the web edition of D.C.   Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Why did the dairy cow cross state lines? After weeks of concern that the U.S.

114

114

STAT

MARCH 22, 2024

  Sign up  to get our biotech newsletter in your inbox. Want to stay on top of the science and politics driving biotech today?  Hi, it’s Meghana. Today, Illumina finally finds an advocate in the EU, a CRISPRed pig kidney is transplanted into a living human, and more. Read the rest…

FDA 109

FDA 109

STAT

MARCH 25, 2024

New biotech newsletter launching this Thursday. Don’t miss out. Today, we discuss the implications of the Supreme Court’s forthcoming mifepristone evaluation on the FDA and the biopharma industry. We also examine how Covid-19 vaccine makers are faring today, and more. Read the rest…

Vaccines 106

Vaccines FDA 106

STAT

MARCH 26, 2024

New biotech newsletter launching this Thursday.    Don’t miss out. Hello, everyone. Damian here with a look at a pivotal FDA approval, good news for a small biotech company, and why not all buyouts are worth writing home about. Read the rest…

FDA 100

FDA 100

STAT

DECEMBER 14, 2023

Sign up for our Morning Rounds newsletter here. Reproductive health is dominating the news and the newsletter this morning. Understand how science, health policy, and medicine shape the world everyday. Good morning. We also have a look at the decade-long battle over a patent for CRISPR. It’s been a rollicking ride.

95

95

STAT

DECEMBER 22, 2023

  Sign up  to get our biotech newsletter in your inbox. Damian here with the final edition of this newsletter for 2023. Want to stay on top of the science and politics driving biotech today?  Hello, everyone. We’re taking a break for the holidays and will be back in your inbox bright and early on Jan.

FDA 100

FDA 100

STAT

MARCH 29, 2024

  Sign up  to get our biotech newsletter in your inbox. Want to stay on top of the science and politics driving biotech today?  Hello, everyone. Damian here with a look at key Supreme Court decision, the latest biotech IPO, and intrigue over Chinese outsourcing. Read the rest…

FDA 104

FDA 104

STAT

APRIL 4, 2024

  Sign up  to get our biotech newsletter in your inbox. Want to stay on top of the science and politics driving biotech today?  Hey, it’s Meghana. Today, we see how the GLP-1s might be harnessed for Parkinson’s, we learn about species de-extinction efforts, and BIO’s CEO tells us why the U.S.

109

109

STAT

APRIL 8, 2024

  STAT’s weekly newsletter  following the flow of money in medicine.  You’re reading the web version of Health Care Inc.,    Sign up  to get it in your inbox every Monday. 

Hospitals 112

Hospitals Insurance 112

STAT

MARCH 21, 2024

  Sign up  to get our biotech newsletter in your inbox. Want to stay on top of the science and politics driving biotech today?  Hello, everyone. Damian here with yet another megaround in biotech, a preview of some hotly anticipated data, and the perils of declining revenue. Read the rest…

106

106

STAT

FEBRUARY 16, 2024

  Sign up  to get our biotech newsletter in your inbox. One more thing: We’ll be taking off Monday for Presidents’ Day, but this newsletter will be back in your inbox bright and early Tuesday morning. Hello, everyone. Damian here with a look at pharma’s struggle to make inroads in D.C.,

FDA 82

FDA 82

STAT

JANUARY 11, 2024

In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The Readout. To stay on top of the latest scoops and live reporting from the San Francisco conference,  join our newsletter list.

FDA 107

FDA 107

STAT

APRIL 17, 2024

  Sign up  to get our biotech newsletter in your inbox. Want to stay on top of the science and politics driving biotech today?  So the GLP-1s strike again: Eli Lilly’s Zepbound seems to work in obstructive sleep apnea as well.

98

98

STAT

APRIL 1, 2024

  Sign up  to get our biotech newsletter in your inbox. Want to stay on top of the science and politics driving biotech today?  Today, we learn about how scientists had a happenstance discovery about tumor-suppressor genes and used them to target aggressive pediatric tumor cells. We see a U.K.

FDA 109

FDA 109

Pharmacy Times

OCTOBER 23, 2023

Thrifty White has created a newsletter sharing the impacts their pharmacists have on patients, including one pharmacist who recognized stroke symptoms and was able to get the patient help.

132

132